American Pharmaceutical Review
SJR0.110
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.110 | Q4 | 3.1% | |
| 2024 | — | — | 0.101 | Q4 | 2.6% | |
| 2023 | — | — | 0.103 | Q4 | 10.5% | |
| 2022 | — | — | 0.127 | Q4 | 22.8% | |
| 2021 | — | — | 0.114 | Q4 | 21.4% | |
| 2020 | — | — | 0.181 | Q3 | 31.2% | |
| 2019 | — | — | 0.141 | Q3 | 25.8% | |
| 2018 | — | — | 0.147 | Q3 | 21.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
1099-8012
country
UScoverage
2002-2020, 2023-2025